Related Experiment Video

Updated: Jul 8, 2026

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
06:04

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Published on: September 2, 2020

TRPV1 antagonists as a potential treatment for hyperalgesia

Louise A Roberts1, Mark Connor

  • 1Pain Management Research Institute, Kolling Institute, Level 4, Main Block, University of Sydney at Royal North Shore Hospital, E25. St. Leonards, NSW 2065, Sydney, Australia. louiser@med.usyd.edu.au

Recent Patents on CNS Drug Discovery
|January 29, 2008
PubMed

Insights

The vanilloid receptor (TRPV1) plays a key role in pain and inflammation. TRPV1 antagonists show promise for treating inflammatory pain by blocking hyperalgesia.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • The vanilloid receptor (TRPV1) is a key ion channel in pain signaling, highly expressed in sensory neurons.
  • TRPV1 activation by heat, capsaicin, and inflammatory mediators leads to pain and inflammation.
  • TRPV1 plays a role in the development of hyperalgesia, a heightened sensitivity to pain.

Purpose of the Study:

  • To review the development of patented TRPV1 antagonists.
  • To evaluate their potential as clinical treatments for pain and inflammation.

Main Methods:

  • Review of scientific literature and patent databases.
  • Analysis of studies on TRPV1 function and antagonist efficacy.
  • Examination of TRPV1 null mouse models.

Main Results:

  • TRPV1 antagonists have shown efficacy in alleviating mechanical and thermal hyperalgesia in preclinical models.
  • TRPV1 null mice exhibit abolished thermal hyperalgesia, supporting TRPV1's role.

Conclusions:

  • TRPV1 antagonists represent a promising therapeutic strategy for managing inflammatory pain.
  • Further clinical development of TRPV1 antagonists is warranted for pain relief.

More Related Videos

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 109:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Thermosensation01:43

Thermosensation

Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...